Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, We Wish To Inform You That The Company Has Received Approval From The Registrar Of Companies (ROC), Hyderabad, Telangana, For Extension Of Time
Filed with BSE · · 3 pages · English
Transgene Biotek Limited on 6ix
Earlier from Transgene Biotek
- Transgene Biotek Limited. Press Release Aug 11 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Transgene Biotek Limited. Press Release Aug 07 2026
- 1)The Board Considered And Approved The Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter Ended 30Th June 2026.2) The Board Considered And Approved The Limited Review Report (Standalone & Consolidated) Of The Comp
- Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On August 07, 2026.
Later from Transgene Biotek
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate: Annexure A
- Compliance-57 (4): Prior intimation to the beginning of the quarter
- Compliance-57 (5): intimation after the end of quarter
- Reg. 32(1) Statement Of Deviation & Variation.
Follow Transgene Biotek into a list and get an email when it puts out news.
Follow Transgene Biotek